Ivermectin/Pyrantel

Verify with FDA CVM →

1,031 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,031
Total Reports
37
Deaths Reported
360.0%
Death Rate

Active Ingredients

Ivermectin/Pyrantel

Administration Routes

OralUnknownTopical

Species Affected

Dog 1,028
Unknown 3

Most Affected Breeds

Retriever - Labrador 169
Crossbred Canine/dog 96
Shepherd Dog - German 62
Retriever - Golden 38
Chihuahua 29
Terrier - Bull - American Pit 29
Boxer (German Boxer) 28
Terrier (unspecified) 28
Shih Tzu 25
Dog (unknown) 24

Most Reported Reactions

Lack of efficacy (endoparasite) - heartworm 281
INEFFECTIVE, HEARTWORM LARVAE 178
Vomiting 149
Lethargy (see also Central nervous system depression in 'Neurological') 86
Diarrhoea 74
Seizure NOS 59
Lack of efficacy - NOS 38
Anorexia 33
Weight loss 31
Lack of efficacy (heartworm) 31
Emesis 30
Decreased appetite 29

Outcome Breakdown

Outcome Unknown
409 (39.8%)
Ongoing
351 (34.1%)
Recovered/Normal
226 (22.0%)
Euthanized
26 (2.5%)
Died
11 (1.1%)
Recovered with Sequela
5 (0.5%)

Data Summary

Metric Value
Total adverse event reports 1,031
Reports involving death 37
Case-fatality rate (reported events) 360.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin/Pyrantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,031 adverse event reports referencing Ivermectin/Pyrantel, including 37 reports in which the animal died — a 360.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin/Pyrantel. Reported administration routes include Oral, Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin/Pyrantel reports are Dog (1,028 reports), Unknown (3 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (169), Crossbred Canine/dog (96), Shepherd Dog - German (62) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin/Pyrantel are Lack of efficacy (endoparasite) - heartworm (281), INEFFECTIVE, HEARTWORM LARVAE (178), Vomiting (149), Lethargy (see also Central nervous system depression in 'Neurological') (86). Of the 1,028 reports with a coded outcome, Outcome Unknown is the leading category at 39.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin/Pyrantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial